Waltham-based energy supplier Global Partners plans to move its headquarters to a recently renovated office complex in Newton ...

Davis Cos. has unveiled its latest plan for the Waltham property after it scrapped a lab proposal and got hit with a lawsuit from the site’s former owner.

She’s recently added a new recurring item to her calendar by joining Waltham Inclusive Neighborhoods, which formed in April of 2023.

The incoming employees at the biopharmaceutical giant will zero in on mRNA, structural biology, and viral vaccine research ...

WALTHAM, Mass. — Two people are being charged after an overnight crash into a utility police in Waltham. According to Waltham ...

MA Television will enable you to develop the skills you need to design and produce great factual television programmes. On this future-facing course, you’ll have opportunities to learn about programme ...

FDA approves AstraZeneca's Datroway, reducing breast cancer progression risk by 37% per TROPION-Breast01 trial results. Datroway's safety profile remains consistent, with 4.2% ILD rate ...

AstraZeneca AZN announced that the FDA has approved its antibody-drug conjugate (ADC), datopotamab deruxtecan (or Dato-DXd), in patients with a certain type of breast cancer. The drug, developed ...

DATROWAY is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo and being jointly developed by Daiichi Sankyo and AstraZeneca. DATROWAY is the ...

With these approvals, AstraZeneca works to lead advancements in treating complex and-life threatening cancers and provide patients with more treatment options to them. The revenue of AstraZaneca ...

(RTTNews) - British drug maker AstraZeneca Plc (AZN.L, AZN) and Daiichi Sankyo (DSKYF.PK) announced Monday that their Datroway (datopotamab deruxtecan) has been approved in the United States for ...